Search

Louise Wang Zhiying Humphrey

Examiner (ID: 17515)

Most Active Art Unit
1648
Art Unit(s)
1657, 1648
Total Applications
628
Issued Applications
269
Pending Applications
52
Abandoned Applications
313

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4595655 [patent_doc_number] => 07981671 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Use of triplex structure DNA in transferring nucleotide sequences' [patent_app_type] => utility [patent_app_number] => 12/153959 [patent_app_country] => US [patent_app_date] => 2008-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 36 [patent_no_of_words] => 14164 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981671.pdf [firstpage_image] =>[orig_patent_app_number] => 12153959 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/153959
Use of triplex structure DNA in transferring nucleotide sequences May 27, 2008 Issued
Array ( [id] => 6631312 [patent_doc_number] => 20100173282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'MUTATIONAL PROFILE IN HIV-1 GAG CLEAVAGE SITE CORRELATED WITH PHENOTYPIC DRUG RESISTANCE' [patent_app_type] => utility [patent_app_number] => 12/601483 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5299 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173282.pdf [firstpage_image] =>[orig_patent_app_number] => 12601483 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/601483
MUTATIONAL PROFILE IN HIV-1 GAG CLEAVAGE SITE CORRELATED WITH PHENOTYPIC DRUG RESISTANCE May 22, 2008 Abandoned
Array ( [id] => 7650907 [patent_doc_number] => 20110300176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Microorganisms for therapy' [patent_app_type] => utility [patent_app_number] => 12/148542 [patent_app_country] => US [patent_app_date] => 2008-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 67569 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300176.pdf [firstpage_image] =>[orig_patent_app_number] => 12148542 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/148542
Microorganisms for therapy Apr 16, 2008 Issued
Array ( [id] => 4888044 [patent_doc_number] => 20080262376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'WIRELESS SENSOR SYSTEM FOR MONITORING SKIN CONDITION USING THE BODY AS COMMUNICATION CONDUIT' [patent_app_type] => utility [patent_app_number] => 12/105046 [patent_app_country] => US [patent_app_date] => 2008-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11460 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262376.pdf [firstpage_image] =>[orig_patent_app_number] => 12105046 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/105046
WIRELESS SENSOR SYSTEM FOR MONITORING SKIN CONDITION USING THE BODY AS COMMUNICATION CONDUIT Apr 16, 2008 Abandoned
Array ( [id] => 8833722 [patent_doc_number] => 08449473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Gas sensor' [patent_app_type] => utility [patent_app_number] => 12/081113 [patent_app_country] => US [patent_app_date] => 2008-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 14235 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12081113 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/081113
Gas sensor Apr 9, 2008 Issued
Array ( [id] => 6201982 [patent_doc_number] => 20110064768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'Immunogenic Compositions' [patent_app_type] => utility [patent_app_number] => 12/595351 [patent_app_country] => US [patent_app_date] => 2008-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12798 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064768.pdf [firstpage_image] =>[orig_patent_app_number] => 12595351 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/595351
Immunogenic Compositions Apr 9, 2008 Abandoned
Array ( [id] => 5296015 [patent_doc_number] => 20090010941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Methods for treating HIV' [patent_app_type] => utility [patent_app_number] => 12/082092 [patent_app_country] => US [patent_app_date] => 2008-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26598 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010941.pdf [firstpage_image] =>[orig_patent_app_number] => 12082092 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/082092
Methods for treating HIV Apr 7, 2008 Abandoned
Array ( [id] => 4778758 [patent_doc_number] => 20080286756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING SEVERE ACUTE RESPIRATORY SYNDROME (SARS)' [patent_app_type] => utility [patent_app_number] => 12/062457 [patent_app_country] => US [patent_app_date] => 2008-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23316 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286756.pdf [firstpage_image] =>[orig_patent_app_number] => 12062457 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/062457
COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING SEVERE ACUTE RESPIRATORY SYNDROME (SARS) Apr 2, 2008 Abandoned
Array ( [id] => 6228913 [patent_doc_number] => 20100183651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Broadly Representative Antigen Sequences and Method for Selection' [patent_app_type] => utility [patent_app_number] => 12/593962 [patent_app_country] => US [patent_app_date] => 2008-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 31487 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183651.pdf [firstpage_image] =>[orig_patent_app_number] => 12593962 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/593962
Broadly Representative Antigen Sequences and Method for Selection Mar 25, 2008 Abandoned
Array ( [id] => 5440992 [patent_doc_number] => 20090092631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'GLYCOSYLATED SPECIFICITY EXCHANGERS THAT INDUCE AN ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/055187 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 21351 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092631.pdf [firstpage_image] =>[orig_patent_app_number] => 12055187 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/055187
GLYCOSYLATED SPECIFICITY EXCHANGERS THAT INDUCE AN ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) RESPONSE Mar 24, 2008 Abandoned
Array ( [id] => 4959719 [patent_doc_number] => 20080274144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'HCV E1 COMPRISING SPECIFIC DISULFIDE BRIDGES' [patent_app_type] => utility [patent_app_number] => 12/053728 [patent_app_country] => US [patent_app_date] => 2008-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16925 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274144.pdf [firstpage_image] =>[orig_patent_app_number] => 12053728 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/053728
HCV E1 COMPRISING SPECIFIC DISULFIDE BRIDGES Mar 23, 2008 Abandoned
Array ( [id] => 5575926 [patent_doc_number] => 20090143288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Peptide-complement conjugates' [patent_app_type] => utility [patent_app_number] => 12/075183 [patent_app_country] => US [patent_app_date] => 2008-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12007 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143288.pdf [firstpage_image] =>[orig_patent_app_number] => 12075183 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/075183
Peptide-complement conjugates Mar 9, 2008 Abandoned
Array ( [id] => 5569744 [patent_doc_number] => 20090253122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Method for measuring resistance of a patient HIV-2 to protease inhibitors' [patent_app_type] => utility [patent_app_number] => 12/073008 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4946 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253122.pdf [firstpage_image] =>[orig_patent_app_number] => 12073008 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/073008
Method for measuring resistance of a patient HIV-2 to protease inhibitors Feb 27, 2008 Abandoned
Array ( [id] => 5336790 [patent_doc_number] => 20090053254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'RECOMBINANT HUMAN ALPHA-FETOPROTEIN AS AN IMMUNOSUPPRESSIVE AGENT' [patent_app_type] => utility [patent_app_number] => 12/036796 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 14707 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053254.pdf [firstpage_image] =>[orig_patent_app_number] => 12036796 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/036796
RECOMBINANT HUMAN ALPHA-FETOPROTEIN AS AN IMMUNOSUPPRESSIVE AGENT Feb 24, 2008 Abandoned
Array ( [id] => 5481018 [patent_doc_number] => 20090203975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'METHOD AND DEVICE FOR TREATING HEEL PAIN OF A PATIENT' [patent_app_type] => utility [patent_app_number] => 12/030560 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5900 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203975.pdf [firstpage_image] =>[orig_patent_app_number] => 12030560 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/030560
METHOD AND DEVICE FOR TREATING HEEL PAIN OF A PATIENT Feb 12, 2008 Abandoned
Array ( [id] => 9073908 [patent_doc_number] => 08551484 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Human antibodies against hepatitis C virus (HCV) and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/527663 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 28477 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12527663 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/527663
Human antibodies against hepatitis C virus (HCV) and uses thereof Feb 12, 2008 Issued
Array ( [id] => 6606744 [patent_doc_number] => 20100099078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'METHOD FOR DESIGNING A DRUG REGIME FOR HIV-INFECTED PATIENTS' [patent_app_type] => utility [patent_app_number] => 12/524120 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 12461 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099078.pdf [firstpage_image] =>[orig_patent_app_number] => 12524120 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/524120
Method for designing a drug regime for HIV-infected patients Jan 22, 2008 Issued
Array ( [id] => 6601564 [patent_doc_number] => 20100048879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'MULTIMERISED HIV FUSION INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/015493 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11068 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048879.pdf [firstpage_image] =>[orig_patent_app_number] => 12015493 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/015493
MULTIMERISED HIV FUSION INHIBITORS Jan 15, 2008 Abandoned
Array ( [id] => 6477611 [patent_doc_number] => 20100285061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'DNA VACCINATION PROTOCOLS' [patent_app_type] => utility [patent_app_number] => 12/522775 [patent_app_country] => US [patent_app_date] => 2008-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 32524 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285061.pdf [firstpage_image] =>[orig_patent_app_number] => 12522775 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/522775
DNA immunization protocols Jan 13, 2008 Issued
Array ( [id] => 4739906 [patent_doc_number] => 20080233559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein' [patent_app_type] => utility [patent_app_number] => 11/962315 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 34204 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233559.pdf [firstpage_image] =>[orig_patent_app_number] => 11962315 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/962315
Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein Dec 20, 2007 Abandoned
Menu